Disallowing the federal tax deduction for prescription drug advertising is being discussed in the Senate Finance Committee as a source of revenue for healthcare reform. House Ways and Means Committee Chairman Charles Rangel (D-NY) has recently been quoted as saying his committee is considering the option also.

It is very important that members of the Ways and Means Committee hear from the advertising industry that this option must be rejected. AAF-RDU urges you to call or email members of the committee and tell them you oppose any limitation on the deduction of advertising expenses – for prescription drugs or any other product. Please circulate this alert to other members of your advertising club and/or company, and continue contacting Senators as well.

Please voice your opposition to Bob Etheridge (NC) – and let him know why you oppose this legislation. You can reach his office by e-mailing staffer David Weinreich at david.weinreich@mail.house.gov.